Loading…
Kevin Joseph Fitzgerald is Director at Ovid Therapeutics. OQRO lists 2 transactions filed with the SEC under this name, the latest on Apr 9, 2026, each linked to the official Form 4.
Director
Disclosures on record
2
Companies involved
1
Ovid TherapeuticsOVID
2 disclosures · Mar 2026 – Apr 2026
Apr 7, 202618Kdisclosed Apr 9
DetailsOfficial recordFeb 26, 202665Kdisclosed Mar 2
DetailsOfficial record